Go Pro
→ PH: Do THESE 4 things to your bank account now … (From Weiss Ratings) (Ad)tc pixel Free INTT Stock Alerts

inTEST (INTT) Financials

inTEST logo
$15.70 -2.01 (-11.35%)
Closing price 04:00 PM Eastern
Extended Trading
$16.04 +0.34 (+2.13%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for inTEST

Annual Income Statements for inTEST

This table shows inTEST's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Consolidated Net Income / (Loss)		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Net Income / (Loss) Continuing Operations		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Total Pre-Tax Income 		2.58 4.21 3.84 5.04 2.60 -1.23 8.40 10 11 3.45 -3.22
Total Operating Income		 2.56 4.15 3.61 5.18 2.55 -1.22 8.46 11 10 3.39 -3.73
Total Gross Profit		 19 20 35 39 29 24 41 53 57 55 49
Total Revenue		 39 40 67 79 61 54 85 117 123 131 114
Operating Revenue		 39 40 67 79 61 54 85 117 123 131 114
Total Cost of Revenue		 20 20 32 39 31 30 44 63 66 75 65
Operating Cost of Revenue		 20 20 32 39 31 30 44 63 66 75 65
Total Operating Expenses		 16 16 31 34 27 25 33 43 47 52 53
Selling, General & Admin Expense		 12 13 20 22 21 19 27 35 39 41 39
Research & Development Expense		 3.94 3.66 4.30 4.91 4.96 5.07 5.53 7.53 7.62 8.55 9.44
Amortization Expense		 - - - - - - - - - 2.55 3.35
Restructuring Charge		 - - - - 0.24 1.29 - - - 0.00 0.85
Total Other Income / (Expense), net		 0.02 0.06 0.23 -0.14 0.06 -0.01 -0.06 -0.58 0.61 0.06 0.50
Interest Expense		 - - - - - - 0.09 0.64 0.68 0.85 0.45
Other Income / (Expense), net		 0.02 0.06 0.23 -0.14 0.06 -0.01 0.03 0.06 1.29 0.91 0.95
Income Tax Expense		 0.72 1.55 2.86 2.01 0.28 -0.34 1.12 1.68 1.71 0.56 -0.70
Basic Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.70 $0.79 $0.82 $0.24 ($0.21)
Weighted Average Basic Shares Outstanding		 10.47M 10.31M 10.28M 10.35M 10.37M 10.26M 10.46M 10.67M 11.46M 12.15M 12.20M
Diluted Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.68 $0.78 $0.79 $0.24 ($0.21)
Weighted Average Diluted Shares Outstanding		 10.49M 10.33M 10.34M 10.38M 10.39M 10.26M 10.73M 10.86M 11.78M 12.24M 12.20M
Weighted Average Basic & Diluted Shares Outstanding		 10.50M 10.40M 10.47M 10.57M 10.43M 10.70M 10.96M 11.12M 12.16M 12.37M 12.50M

Quarterly Income Statements for inTEST

This table shows inTEST's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 2.28 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79
Consolidated Net Income / (Loss)		 2.28 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79
Net Income / (Loss) Continuing Operations		 2.28 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79
Total Pre-Tax Income 		2.72 1.57 0.79 0.30 0.57 1.80 -2.79 -0.58 -1.23 1.38 0.98
Total Operating Income		 2.47 1.11 0.49 0.34 0.49 2.08 -2.88 -0.93 -1.19 1.28 0.95
Total Gross Profit		 14 12 13 14 14 15 11 12 11 15 15
Total Revenue		 31 28 30 34 30 37 27 28 26 33 34
Operating Revenue		 31 28 30 34 30 37 27 28 26 33 34
Total Cost of Revenue		 16 15 17 20 16 22 16 16 15 18 18
Operating Cost of Revenue		 16 15 17 20 16 22 16 16 15 18 18
Total Operating Expenses		 12 11 13 13 14 12 14 13 12 14 14
Selling, General & Admin Expense		 10 9.41 10 10 10 10 10 9.59 8.89 10 10
Research & Development Expense		 1.80 1.93 1.98 2.22 2.18 2.17 2.45 2.25 2.34 2.41 2.59
Amortization Expense		 - - 0.60 0.90 0.94 - 0.81 0.85 0.84 0.84 0.78
Restructuring Charge		 - - 0.00 0.00 0.00 - 0.31 0.22 0.12 0.21 0.74
Total Other Income / (Expense), net		 0.26 0.46 0.30 -0.04 0.08 -0.28 0.09 0.34 -0.03 0.10 0.02
Interest Expense		 0.17 0.15 0.14 0.25 0.22 0.23 0.15 0.12 0.10 0.08 0.08
Other Income / (Expense), net		 0.42 0.61 0.44 0.21 0.30 -0.04 0.24 0.46 0.06 0.19 0.10
Income Tax Expense		 0.45 0.11 0.13 0.07 0.07 0.30 -0.46 -0.08 -0.29 0.13 0.19
Basic Earnings per Share		 $0.19 $0.12 $0.06 $0.02 $0.04 $0.12 ($0.19) ($0.04) ($0.08) $0.10 $0.06
Weighted Average Basic Shares Outstanding		 11.89M 11.46M 12.03M 12.23M 12.19M 12.15M 12.18M 12.22M 12.21M 12.20M 12.25M
Diluted Earnings per Share		 $0.19 $0.11 $0.05 $0.02 $0.04 $0.13 ($0.19) ($0.04) ($0.08) $0.10 $0.06
Weighted Average Diluted Shares Outstanding		 12.21M 11.78M 12.16M 12.33M 12.25M 12.24M 12.18M 12.22M 12.21M 12.20M 12.42M
Weighted Average Basic & Diluted Shares Outstanding		 12.16M 12.16M 12.49M 12.52M 12.37M 12.37M 12.49M 12.48M 12.48M 12.50M 12.56M

Annual Cash Flow Statements for inTEST

This table details how cash moves in and out of inTEST's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 2.58 2.90 -15 4.57 -10 2.67 11 -6.62 31 -25 -1.77
Net Cash From Operating Activities		 3.50 4.29 7.24 11 -8.41 3.25 11 -1.39 16 3.82 7.32
Net Cash From Continuing Operating Activities		 3.50 4.29 7.24 11 -8.41 3.25 11 -1.39 16 3.82 7.32
Net Income / (Loss) Continuing Operations		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Consolidated Net Income / (Loss)		 1.86 2.66 0.98 3.04 2.32 -0.90 7.28 8.46 9.34 2.89 -2.53
Depreciation Expense		 0.75 0.60 1.78 1.87 3.19 3.17 3.15 4.73 4.68 5.39 6.80
Non-Cash Adjustments To Reconcile Net Income		 0.72 0.64 5.96 12 -11 0.56 0.71 1.41 1.08 1.21 0.01
Changes in Operating Assets and Liabilities, net		 0.16 0.39 -1.47 -6.43 -3.29 0.41 -0.30 -16 1.10 -5.67 3.04
Net Cash From Investing Activities		 -0.60 -0.34 -23 -6.34 -0.62 -0.65 -21 -1.17 -1.29 -20 -1.63
Net Cash From Continuing Investing Activities		 -0.60 -0.34 -23 -6.34 -0.62 -0.65 -21 -1.17 -1.29 -20 -1.63
Purchase of Property, Plant & Equipment		 -0.60 -0.34 -0.75 -2.21 -0.62 -0.66 -0.99 -1.37 -1.29 -1.32 -1.63
Acquisitions		 - 0.00 -22 -4.12 - 0.00 -20 -0.18 0.00 -19 0.00
Net Cash From Financing Activities		 -0.16 -0.98 -0.06 0.00 -1.14 -0.07 22 -3.73 16 -8.64 -8.23
Net Cash From Continuing Financing Activities		 -0.16 -0.98 -0.06 0.00 -1.14 -0.07 22 -3.73 16 -8.64 -8.23
Repayment of Debt		 - - - - 0.00 -5.63 -0.40 -3.96 -4.10 -7.84 -8.35
Repurchase of Common Equity		 -0.16 -0.98 -0.06 0.00 -1.14 -0.07 - - 0.00 -1.04 0.00
Other Financing Activities, net		 - - - - - - 1.63 0.23 0.47 0.24 0.13
Other Net Changes in Cash		 - - - - -0.08 0.14 -0.28 -0.32 0.16 -0.56 0.77
Cash Interest Paid		 - - - - - - - - 0.69 0.88 0.46
Cash Income Taxes Paid		 0.79 0.64 3.47 2.86 0.54 0.05 1.32 3.92 3.24 3.07 0.19

Quarterly Cash Flow Statements for inTEST

This table details how cash moves in and out of inTEST's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 4.25 3.58 -18 -6.96 -2.40 1.86 2.22 -3.66 2.71 -3.04 -2.37
Net Cash From Operating Activities		 6.18 4.68 2.08 -5.09 4.25 2.59 5.54 -0.69 3.49 -1.02 -3.32
Net Cash From Continuing Operating Activities		 6.18 4.68 2.08 -5.06 4.22 2.59 5.54 -0.69 3.49 -1.02 -3.32
Net Income / (Loss) Continuing Operations		 2.28 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79
Consolidated Net Income / (Loss)		 2.28 1.46 0.66 0.23 0.50 1.50 -2.33 -0.50 -0.94 1.24 0.79
Depreciation Expense		 1.17 1.17 1.28 1.52 1.66 0.92 1.74 1.57 1.70 1.79 1.64
Non-Cash Adjustments To Reconcile Net Income		 0.37 0.14 0.08 1.49 0.51 0.43 -0.09 -0.10 0.05 0.15 0.69
Changes in Operating Assets and Liabilities, net		 2.36 1.92 0.05 -8.31 1.56 -0.27 6.21 -1.65 2.68 -4.20 -6.44
Net Cash From Investing Activities		 -0.27 -0.31 -19 -0.14 -0.51 -0.16 -0.23 -0.46 -0.41 -0.53 -0.64
Net Cash From Continuing Investing Activities		 -0.27 -0.31 -19 -0.14 -0.51 -0.16 -0.23 -0.46 -0.41 -0.53 -0.64
Purchase of Property, Plant & Equipment		 -0.27 -0.31 -0.34 -0.32 -0.51 -0.16 -0.23 -0.46 -0.41 -0.53 -0.64
Net Cash From Financing Activities		 -1.53 -0.97 -0.87 -0.98 -6.31 -0.48 -3.41 -2.20 -1.23 -1.39 1.67
Net Cash From Continuing Financing Activities		 -1.53 -0.97 -0.87 -1.06 -6.22 -0.48 -3.44 -2.20 -1.23 -1.39 1.67
Repayment of Debt		 -1.03 -1.03 -1.18 -1.95 -4.20 -0.51 -1.03 -2.21 -1.26 -1.43 1.16
Other Financing Activities, net		 -0.50 0.06 0.03 0.04 0.14 0.03 0.01 0.02 0.03 0.04 0.50
Effect of Exchange Rate Changes		 - - - - 0.17 - - - - - -0.08
Cash Interest Paid		 - - 0.15 0.26 0.23 - 0.14 0.12 0.10 0.09 0.09
Cash Income Taxes Paid		 0.93 0.25 0.10 1.05 -0.01 1.93 0.03 0.11 -0.05 0.10 -0.57

Annual Balance Sheets for inTEST

This table presents inTEST's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 40 43 62 67 60 62 104 110 135 152 151
Total Current Assets		 34 38 31 36 25 27 52 60 86 79 79
Cash & Equivalents		 26 29 13 18 7.61 10 21 13 45 20 14
Restricted Cash		 - - - - - - 0.00 1.14 - 0.00 3.84
Accounts Receivable		 4.40 5.38 12 11 9.30 8.44 17 21 18 29 26
Inventories, net		 3.52 3.68 4.97 6.52 7.18 7.48 13 23 20 27 32
Prepaid Expenses		 0.64 0.34 0.58 0.68 0.81 0.78 1.48 1.70 2.25 2.65 3.11
Plant, Property, & Equipment, net		 1.11 0.94 1.54 2.72 2.42 2.35 2.69 3.13 3.19 4.46 4.78
Total Noncurrent Assets		 4.61 3.89 30 29 32 33 49 47 46 69 68
Goodwill		 1.71 1.71 14 14 14 14 21 22 22 31 32
Intangible Assets		 1.10 0.88 16 15 14 12 22 19 17 26 25
Noncurrent Deferred & Refundable Income Taxes		 1.25 1.11 - - - - 0.00 0.28 1.44 0.07 0.78
Other Noncurrent Operating Assets		 0.20 0.03 0.03 0.03 4.87 6.42 5.96 6.34 6.00 12 9.89
Total Liabilities & Shareholders' Equity		 40 43 62 67 60 62 104 110 135 152 151
Total Liabilities		 4.06 5.06 23 24 15 17 49 45 39 52 48
Total Current Liabilities		 4.06 5.06 14 21 8.36 8.86 25 27 24 32 36
Short-Term Debt		 - 0.00 5.36 12 - 0.00 4.10 4.10 4.10 7.49 6.06
Accounts Payable		 0.91 1.37 2.03 1.79 1.98 2.42 4.28 7.39 5.52 17 21
Current Deferred Revenue		 - 0.07 0.89 1.26 0.46 0.40 6.04 4.50 3.80 4.99 6.39
Current Deferred & Payable Income Tax Liabilities		 0.03 0.58 1.20 0.70 0.87 0.83 2.02 1.41 1.04 - 0.00
Other Current Liabilities		 0.34 0.17 2.17 1.11 1.80 2.02 2.64 3.21 3.40 1.99 2.10
Total Noncurrent Liabilities		 0.00 0.00 8.79 2.89 6.52 8.42 24 18 14 21 12
Long-Term Debt		 - - - - - 0.00 16 12 7.94 7.54 1.41
Capital Lease Obligations		 - - - - 3.79 6.05 5.25 4.71 3.50 9.02 7.40
Noncurrent Deferred Revenue		 - 0.00 0.44 - - - - 0.00 1.33 1.43 1.06
Other Noncurrent Operating Liabilities		 - 0.00 5.74 0.20 0.46 0.45 1.38 1.49 1.48 2.56 2.07
Commitments & Contingencies		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 36 38 39 43 45 45 55 65 96 100 104
Total Preferred & Common Equity		 36 38 39 43 45 45 55 65 96 100 104
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 36 38 39 43 45 45 55 65 96 100 104
Common Stock		 26 26 26 27 26 27 30 32 55 58 60
Retained Earnings		 9.01 12 13 16 18 17 24 33 42 45 43
Accumulated Other Comprehensive Income / (Loss)		 0.73 0.64 0.88 0.78 0.67 0.89 0.59 0.22 0.41 -2.14 2.46
Other Equity Adjustments		 0.00 - - - 0.00 - - -0.21 - -0.94 -0.96

Quarterly Balance Sheets for inTEST

This table presents inTEST's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 135 160 161 158 148 150 148 151
Total Current Assets		 87 85 81 81 75 75 75 80
Cash & Equivalents		 42 27 20 18 22 19 16 13
Restricted Cash		 0.00 - - - - - 4.87 2.82
Accounts Receivable		 21 23 30 28 21 23 21 30
Inventories, net		 22 31 29 32 28 28 28 30
Prepaid Expenses		 2.01 3.87 2.38 3.21 4.09 4.64 5.10 3.34
Plant, Property, & Equipment, net		 3.14 4.77 4.53 4.57 4.43 4.68 4.72 4.97
Total Noncurrent Assets		 46 69 75 73 69 70 68 66
Goodwill		 22 33 35 32 31 32 32 32
Intangible Assets		 17 29 27 28 26 27 26 24
Noncurrent Deferred & Refundable Income Taxes		 1.38 0.00 0.00 0.00 0.00 0.00 0.00 0.93
Other Noncurrent Operating Assets		 5.70 7.17 13 12 11 11 10 9.25
Total Liabilities & Shareholders' Equity		 135 160 161 158 148 150 148 151
Total Liabilities		 41 60 61 58 49 47 46 46
Total Current Liabilities		 27 40 36 36 31 31 32 36
Short-Term Debt		 4.10 9.63 12 8.27 6.88 6.43 6.53 7.42
Accounts Payable		 7.30 11 8.28 9.21 17 17 17 19
Current Deferred Revenue		 4.40 5.60 5.49 6.98 4.94 5.60 6.56 6.79
Current Deferred & Payable Income Tax Liabilities		 1.12 0.51 0.00 0.00 - - - 0.73
Other Current Liabilities		 3.29 4.04 3.80 3.99 2.06 2.10 2.06 2.12
Total Noncurrent Liabilities		 15 21 25 22 17 16 14 10
Long-Term Debt		 8.97 11 9.11 7.82 4.95 3.67 2.34 1.12
Capital Lease Obligations		 3.50 4.64 10 9.65 8.60 8.32 7.90 6.86
Noncurrent Deferred Revenue		 1.03 1.21 1.26 1.21 1.41 1.37 1.11 0.82
Other Noncurrent Operating Liabilities		 1.40 2.77 2.58 2.61 2.09 2.23 2.18 1.66
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 94 99 100 100 99 103 102 104
Total Preferred & Common Equity		 94 99 100 100 99 103 102 104
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 94 99 100 100 99 103 102 104
Common Stock		 54 57 58 57 58 59 59 60
Retained Earnings		 41 43 43 44 43 42 41 43
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.31 -0.43 0.39 -0.68 2.57 2.39 1.72
Other Equity Adjustments		 -0.90 -0.93 -0.94 -0.94 -0.95 -0.96 -0.96 -1.00

Annual Metrics And Ratios for inTEST

This table displays calculated financial ratios and metrics derived from inTEST's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 10,562,678.00 10,376,770.00 10,413,058.00 10,489,958.00 10,494,761.00 10,529,123.00 10,873,392.00 11,022,949.00 24,326,010.00 - 12,483,433.00
DEI Adjusted Shares Outstanding		 10,562,678.00 10,376,770.00 10,413,058.00 10,489,958.00 10,494,761.00 10,529,123.00 10,873,392.00 11,022,949.00 24,326,010.00 - 12,483,433.00
DEI Earnings Per Adjusted Shares Outstanding		 0.18 0.26 0.09 0.29 0.22 -0.09 0.67 0.77 0.38 - -0.20
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -6.96% 3.44% 66.06% 17.61% -22.79% -11.27% 57.70% 37.64% 5.54% 5.99% -12.90%
EBITDA Growth		 -43.65% 44.02% 16.87% 23.09% -16.16% -66.48% 498.87% 33.33% 5.78% -40.94% -58.48%
EBIT Growth		 -47.38% 62.87% -8.77% 31.40% -48.36% -147.27% 789.76% 26.96% 8.78% -63.33% -164.47%
NOPAT Growth		 -46.40% 41.91% -64.98% 240.06% -27.14% -137.48% 960.71% 21.94% -1.28% -67.82% -191.79%
Net Income Growth		 -45.89% 42.83% -63.32% 211.49% -23.54% -138.54% 913.74% 16.17% 10.41% -69.05% -187.41%
EPS Growth		 -45.45% 44.44% -65.38% 222.22% -24.14% -140.91% 855.56% 14.71% 1.28% -69.62% -187.50%
Operating Cash Flow Growth		 -31.80% 22.58% 68.89% 51.34% -176.69% 138.64% 233.81% -112.81% 1,266.52% -76.42% 91.44%
Free Cash Flow Firm Growth		 -32.13% 21.22% -710.45% 87.24% 41.33% 77.33% -2,991.88% 70.34% 507.66% -356.52% 102.80%
Invested Capital Growth		 -9.43% -8.75% 246.35% 18.71% 10.44% -1.20% 45.79% 20.81% -6.56% 56.35% -3.44%
Revenue Q/Q Growth		 -4.71% 6.16% 15.79% -1.19% -7.36% 2.40% 9.67% 9.41% -3.54% 7.15% -3.22%
EBITDA Q/Q Growth		 -29.06% 56.55% -50.84% 141.66% 32.02% -35.47% 9.01% 32.61% -11.97% 0.75% 7.74%
EBIT Q/Q Growth		 -33.99% 72.42% -61.47% 390.09% 78.48% -854.26% 10.10% 52.99% -16.63% 7.96% -26.17%
NOPAT Q/Q Growth		 -33.63% 59.44% -85.70% 495.95% 176.14% -788.32% 11.29% 51.19% -20.69% 32.70% -27.48%
Net Income Q/Q Growth		 -33.23% 57.28% -85.10% 512.08% 188.09% -528.23% 10.08% 53.72% -16.07% 1.72% -11.52%
EPS Q/Q Growth		 -30.77% 44.44% -85.48% 583.33% 266.67% -550.00% 11.48% 52.94% -19.39% 9.09% -16.67%
Operating Cash Flow Q/Q Growth		 -44.13% 84.83% -6.37% 18.15% -55.85% 3.90% 20.86% -47.92% 17.50% -35.41% -33.04%
Free Cash Flow Firm Q/Q Growth		 -46.20% 123.54% -39.44% 62.12% -159.31% 92.40% -186.00% 87.91% 27.58% 6.95% -88.52%
Invested Capital Q/Q Growth		 -4.62% -13.67% -2.84% -3.78% 11.67% -2.12% 68.83% 4.37% -3.27% -3.82% 2.96%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 48.08% 50.66% 51.93% 50.15% 48.18% 44.78% 48.57% 45.74% 46.21% 42.41% 42.98%
EBITDA Margin		 8.58% 11.95% 8.41% 8.80% 9.56% 3.61% 13.71% 13.28% 13.31% 7.42% 3.54%
Operating Margin		 6.59% 10.31% 5.41% 6.59% 4.20% -2.26% 9.97% 9.18% 8.47% 2.60% -3.27%
EBIT Margin		 6.64% 10.46% 5.75% 6.42% 4.29% -2.29% 10.00% 9.23% 9.51% 3.29% -2.44%
Profit (Net Income) Margin		 4.79% 6.61% 1.46% 3.87% 3.83% -1.66% 8.58% 7.24% 7.58% 2.21% -2.22%
Tax Burden Percent		 72.05% 63.18% 25.40% 60.22% 89.17% 72.71% 86.68% 83.40% 84.56% 83.70% 78.43%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.95% 94.11% 94.21% 80.33% 116.23%
Effective Tax Rate		 27.95% 36.82% 74.60% 39.78% 10.83% 0.00% 13.32% 16.60% 15.44% 16.30% 0.00%
Return on Invested Capital (ROIC)		 17.79% 27.77% 4.57% 9.15% 5.84% -2.10% 14.77% 13.76% 12.83% 3.33% -2.55%
ROIC Less NNEP Spread (ROIC-NNEP)		 17.72% 27.63% 4.25% 10.33% 4.84% -1.06% 46.24% 4.36% 8.48% 2.94% 13.00%
Return on Net Nonoperating Assets (RNNOA)		 -12.49% -20.56% -2.04% -1.76% -0.54% 0.10% -0.15% 0.37% -1.24% -0.39% 0.07%
Return on Equity (ROE)		 5.30% 7.21% 2.53% 7.39% 5.29% -2.00% 14.63% 14.13% 11.59% 2.95% -2.48%
Cash Return on Invested Capital (CROIC)		 27.68% 36.92% -105.82% -7.96% -4.09% -0.89% -22.48% -5.09% 19.61% -40.63% 0.95%
Operating Return on Assets (OROA)		 6.56% 10.16% 7.29% 7.78% 4.10% -2.02% 10.23% 10.08% 9.58% 3.00% -1.83%
Return on Assets (ROA)		 4.73% 6.42% 1.85% 4.68% 3.66% -1.47% 8.78% 7.91% 7.63% 2.01% -1.66%
Return on Common Equity (ROCE)		 5.30% 7.21% 2.53% 7.39% 5.29% -2.00% 14.63% 14.13% 11.59% 2.95% -2.48%
Return on Equity Simple (ROE_SIMPLE)		 5.18% 7.03% 2.48% 7.08% 5.18% -2.00% 13.28% 13.03% 9.70% 2.90% 0.00%
Net Operating Profit after Tax (NOPAT)		 1.85 2.62 0.92 3.12 2.27 -0.85 7.33 8.94 8.83 2.84 -2.61
NOPAT Margin		 4.75% 6.51% 1.37% 3.97% 3.75% -1.58% 8.64% 7.65% 7.16% 2.17% -2.29%
Net Nonoperating Expense Percent (NNEP)		 0.06% 0.14% 0.31% -1.18% 1.00% -1.04% -31.47% 9.40% 4.36% 0.39% -15.56%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 7.89% 2.29% -2.20%
Cost of Revenue to Revenue		 51.92% 49.34% 48.07% 49.85% 51.82% 55.22% 51.43% 54.26% 53.79% 57.59% 57.02%
SG&A Expenses to Revenue		 31.37% 31.25% 29.64% 28.53% 35.40% 35.24% 31.75% 30.12% 31.57% 33.27% 34.27%
R&D to Revenue		 10.12% 9.10% 6.44% 6.25% 8.18% 9.42% 6.52% 6.44% 6.18% 6.54% 8.29%
Operating Expenses to Revenue		 41.49% 40.35% 46.52% 43.56% 43.98% 47.04% 38.60% 36.57% 37.74% 39.81% 46.25%
Earnings before Interest and Taxes (EBIT)		 2.58 4.21 3.84 5.04 2.60 -1.23 8.49 11 12 4.30 -2.77
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3.34 4.81 5.62 6.91 5.80 1.94 12 16 16 9.69 4.02
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.24 1.26 2.29 1.50 1.39 1.53 2.52 1.75 1.72 1.07 0.90
Price to Tangible Book Value (P/TBV)		 1.35 1.36 9.45 4.52 3.58 3.68 11.78 4.58 2.85 2.49 2.01
Price to Revenue (P/Rev)		 1.15 1.19 1.35 0.82 1.03 1.27 1.63 0.97 1.34 0.81 0.82
Price to Earnings (P/E)		 24.01 17.96 92.38 21.17 26.89 0.00 18.99 13.42 17.70 36.77 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.17% 5.57% 1.08% 4.72% 3.72% 0.00% 5.27% 7.45% 5.65% 2.72% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.92 2.12 2.63 1.58 1.43 1.59 2.42 1.68 2.04 1.06 0.90
Enterprise Value to Revenue (EV/Rev)		 0.49 0.48 1.23 0.75 0.97 1.19 1.68 1.03 1.10 0.85 0.79
Enterprise Value to EBITDA (EV/EBITDA)		 5.68 3.98 14.62 8.48 10.11 32.99 12.24 7.72 8.27 11.40 22.38
Enterprise Value to EBIT (EV/EBIT)		 7.34 4.55 21.40 11.62 22.51 0.00 16.78 11.11 11.57 25.70 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 10.28 7.30 89.54 18.79 25.79 0.00 19.43 13.40 15.37 38.91 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 5.42 4.46 11.34 5.35 0.00 19.74 13.14 0.00 8.37 28.92 12.31
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.60 5.49 0.00 0.00 0.00 0.00 0.00 0.00 10.06 0.00 92.80
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.14 0.28 0.08 0.14 0.46 0.32 0.16 0.24 0.14
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.08 0.14 0.39 0.26 0.12 0.17 0.09
Financial Leverage		 -0.70 -0.74 -0.48 -0.17 -0.11 -0.09 0.00 0.09 -0.15 -0.13 0.01
Leverage Ratio		 1.12 1.12 1.37 1.58 1.45 1.36 1.67 1.79 1.52 1.46 1.49
Compound Leverage Factor		 1.12 1.12 1.37 1.58 1.45 1.36 1.65 1.68 1.43 1.18 1.73
Debt to Total Capital		 0.00% 0.00% 12.00% 22.10% 7.80% 11.91% 31.62% 24.30% 13.90% 19.42% 12.55%
Short-Term Debt to Total Capital		 0.00% 0.00% 12.00% 22.10% 0.00% 0.00% 5.11% 4.78% 3.67% 6.05% 5.12%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 7.80% 11.91% 26.50% 19.52% 10.23% 13.37% 7.43%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 88.00% 77.90% 92.20% 88.09% 68.38% 75.70% 86.10% 80.58% 87.45%
Debt to EBITDA		 0.00 0.00 0.95 1.76 0.65 3.11 2.18 1.34 0.95 2.48 3.70
Net Debt to EBITDA		 0.00 0.00 -1.41 -0.82 -0.66 -2.18 0.36 0.40 -1.81 0.44 -0.79
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.65 3.11 1.83 1.08 0.70 1.71 2.19
Debt to NOPAT		 0.00 0.00 5.84 3.90 1.67 -7.10 3.46 2.33 1.76 8.47 -5.70
Net Debt to NOPAT		 0.00 0.00 -8.65 -1.83 -1.68 4.96 0.57 0.70 -3.37 1.49 1.22
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 1.67 -7.10 2.90 1.87 1.30 5.83 -3.38
Altman Z-Score		 9.01 8.23 4.20 3.58 4.43 3.91 3.42 3.67 4.76 2.95 2.60
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.44 7.52 2.15 1.66 2.98 3.04 2.08 2.24 3.53 2.47 2.20
Quick Ratio		 7.42 6.72 1.77 1.33 2.02 2.11 1.50 1.29 2.61 1.54 1.12
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2.87 3.48 -21 -2.71 -1.59 -0.36 -11 -3.31 13 -35 0.97
Operating Cash Flow to CapEx		 583.97% 1,264.90% 1,021.44% 495.48% -1,355.65% 501.23% 1,090.74% -101.76% 1,255.07% 288.60% 448.22%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -125.38 -5.21 19.87 -40.91 2.16
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 121.82 -2.19 23.86 4.52 16.26
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 110.65 -4.34 21.96 2.95 12.63
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.99 0.97 1.27 1.21 0.96 0.88 1.02 1.09 1.01 0.91 0.75
Accounts Receivable Turnover		 8.25 8.23 7.62 6.91 6.11 6.07 6.80 6.19 6.26 5.48 4.11
Inventory Turnover		 5.54 5.52 7.43 6.82 4.59 4.06 4.29 3.58 3.11 3.21 2.22
Fixed Asset Turnover		 32.68 39.13 53.76 36.90 23.62 22.57 33.70 40.15 39.01 34.18 24.65
Accounts Payable Turnover		 18.84 17.43 18.89 20.51 16.67 13.48 13.02 10.86 10.27 11.14 3.36
Days Sales Outstanding (DSO)		 44.25 44.33 47.93 52.80 59.75 60.12 53.69 58.97 58.30 66.57 88.80
Days Inventory Outstanding (DIO)		 65.88 66.16 49.12 53.53 79.55 90.01 85.03 102.00 117.37 113.78 164.26
Days Payable Outstanding (DPO)		 19.37 20.94 19.32 17.80 21.89 27.07 28.03 33.61 35.54 32.76 108.77
Cash Conversion Cycle (CCC)		 90.76 89.56 77.72 88.53 117.40 123.07 110.69 127.36 140.13 147.59 144.29
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 9.87 9.00 31 37 41 40 59 71 66 104 100
Invested Capital Turnover		 3.75 4.26 3.33 2.30 1.56 1.32 1.71 1.80 1.79 1.53 1.11
Increase / (Decrease) in Invested Capital		 -1.03 -0.86 22 5.83 3.87 -0.49 18 12 -4.67 37 -3.58
Enterprise Value (EV)		 19 19 82 59 59 64 142 120 136 111 90
Market Capitalization		 45 48 90 64 62 68 138 114 165 106 93
Book Value per Share		 $3.40 $3.64 $3.77 $4.09 $4.27 $4.25 $5.04 $5.89 $7.92 $8.06 $8.30
Tangible Book Value per Share		 $3.14 $3.39 $0.92 $1.36 $1.66 $1.77 $1.08 $2.25 $4.77 $3.45 $3.72
Total Capital		 36 38 45 55 49 51 80 86 112 124 118
Total Debt		 0.00 0.00 5.36 12 3.79 6.05 25 21 16 24 15
Total Long-Term Debt		 0.00 0.00 0.00 0.00 3.79 6.05 21 17 11 17 8.81
Net Debt		 -26 -29 -7.94 -5.69 -3.82 -4.23 4.15 6.27 -30 4.22 -3.19
Capital Expenditures (CapEx)		 0.60 0.34 0.71 2.21 0.62 0.65 0.99 1.37 1.29 1.32 1.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 4.50 4.34 8.65 8.51 8.92 7.83 9.91 23 20 35 31
Debt-free Net Working Capital (DFNWC)		 30 33 22 26 17 18 31 37 66 54 49
Net Working Capital (NWC)		 30 33 17 14 17 18 27 33 61 47 43
Net Nonoperating Expense (NNE)		 -0.02 -0.04 -0.06 0.08 -0.05 0.04 0.05 0.48 -0.51 -0.05 -0.08
Net Nonoperating Obligations (NNO)		 -26 -29 -8.11 -5.87 -3.96 -4.37 4.05 6.17 -30 4.12 -3.19
Total Depreciation and Amortization (D&A)		 0.75 0.60 1.78 1.87 3.19 3.17 3.15 4.73 4.68 5.39 6.80
Debt-free, Cash-free Net Working Capital to Revenue		 11.56% 10.79% 12.94% 10.83% 14.71% 14.55% 11.68% 19.44% 16.48% 26.42% 27.14%
Debt-free Net Working Capital to Revenue		 77.67% 81.91% 32.84% 33.57% 27.26% 33.64% 36.65% 31.91% 53.19% 41.59% 43.00%
Net Working Capital to Revenue		 77.67% 81.91% 24.82% 18.08% 27.26% 33.64% 31.82% 28.40% 49.86% 35.86% 37.67%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.70 $0.00 $0.82 $0.24 ($0.21)
Adjusted Weighted Average Basic Shares Outstanding		 10.47M 10.31M 10.28M 10.35M 10.37M 10.26M 10.46M 0.00 11.46M 12.15M 12.20M
Adjusted Diluted Earnings per Share		 $0.18 $0.26 $0.09 $0.29 $0.22 ($0.09) $0.68 $0.00 $0.79 $0.24 ($0.21)
Adjusted Weighted Average Diluted Shares Outstanding		 10.49M 10.33M 10.34M 10.38M 10.39M 10.26M 10.73M 0.00 11.78M 12.24M 12.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 10.50M 10.40M 10.47M 10.57M 10.43M 10.70M 10.96M 0.00 12.16M 12.37M 12.50M
Normalized Net Operating Profit after Tax (NOPAT)		 1.85 2.62 2.53 3.12 2.49 0.05 7.33 8.94 8.83 2.84 -2.01
Normalized NOPAT Margin		 4.75% 6.51% 3.78% 3.97% 4.10% 0.09% 8.64% 7.65% 7.16% 2.17% -1.77%
Pre Tax Income Margin		 6.64% 10.46% 5.75% 6.42% 4.29% -2.29% 9.90% 8.68% 8.96% 2.64% -2.83%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 95.40 16.98 17.27 5.08 -6.16
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 82.39 14.08 13.00 3.36 -5.79
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 84.24 14.83 15.37 3.52 -9.79
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 71.22 11.93 11.10 1.79 -9.42
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 8.33% 36.79% 6.36% 0.00% 49.18% -8.27% 0.00% 0.00% 0.00% 36.04% 0.00%

Quarterly Metrics And Ratios for inTEST

This table displays calculated financial ratios and metrics derived from inTEST's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 12,157,456.00 24,326,010.00 12,164,698.00 12,489,642.00 12,516,280.00 - 12,373,276.00 12,492,809.00 12,477,676.00 12,483,433.00 12,495,544.00
DEI Adjusted Shares Outstanding		 12,157,456.00 24,326,010.00 12,164,698.00 12,489,642.00 12,516,280.00 - 12,373,276.00 12,492,809.00 12,477,676.00 12,483,433.00 12,495,544.00
DEI Earnings Per Adjusted Shares Outstanding		 0.19 0.06 0.05 0.02 0.04 - -0.19 -0.04 -0.08 0.10 0.06
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.55% -13.95% -6.56% 4.40% -2.16% 31.27% -10.69% -17.24% -13.33% -10.33% 27.21%
EBITDA Growth		 -7.06% -43.60% -53.51% -56.03% -39.57% 2.49% -140.56% -46.89% -76.70% 9.77% 401.12%
EBIT Growth		 -10.16% -57.65% -74.08% -84.50% -72.74% 18.44% -384.47% -184.52% -243.65% -28.24% 140.08%
NOPAT Growth		 -21.34% -69.43% -85.83% -90.59% -79.47% 68.40% -587.30% -348.54% -297.11% -33.62% 138.20%
Net Income Growth		 -9.79% -55.15% -76.50% -91.77% -78.26% 3.37% -451.81% -318.70% -289.49% -17.35% 133.88%
EPS Growth		 -17.39% -63.33% -80.00% -91.67% -78.95% 18.18% -480.00% -300.00% -300.00% -23.08% 131.58%
Operating Cash Flow Growth		 334.22% 106.35% -16.47% -278.10% -31.23% -44.75% 166.75% 86.48% -17.86% -139.51% -159.89%
Free Cash Flow Firm Growth		 104.92% 164.13% -297.10% -1,112.23% -2,679.15% -727.10% 88.55% 120.86% 124.84% 113.21% -100.01%
Invested Capital Growth		 0.81% -6.56% 34.85% 51.83% 57.25% 56.35% 0.83% -7.66% -9.72% -3.44% 6.56%
Revenue Q/Q Growth		 -4.97% -9.88% 6.96% 13.97% -10.94% 20.91% -27.23% 5.61% -6.73% 25.10% 3.24%
EBITDA Q/Q Growth		 -13.98% -28.82% -23.48% -6.16% 18.23% 20.73% -130.28% 222.88% -48.14% 468.83% -16.93%
EBIT Q/Q Growth		 -18.36% -40.54% -46.07% -40.78% 43.53% 158.38% -229.52% 82.40% -143.97% 229.06% -27.65%
NOPAT Q/Q Growth		 -25.65% -50.07% -59.84% -36.91% 62.27% 309.57% -216.22% 67.82% -28.69% 237.93% -33.11%
Net Income Q/Q Growth		 -18.47% -36.10% -54.50% -65.26% 115.22% 203.84% -254.85% 78.40% -86.48% 232.52% -36.52%
EPS Q/Q Growth		 -20.83% -42.11% -54.55% -60.00% 100.00% 225.00% -246.15% 78.95% -100.00% 225.00% -40.00%
Operating Cash Flow Q/Q Growth		 116.20% -24.23% -55.68% -345.30% 183.48% -39.12% 113.95% -112.43% 607.27% -129.28% -224.36%
Free Cash Flow Firm Q/Q Growth		 148.96% 277.49% -532.70% -51.57% -4.17% 8.22% 92.12% 376.28% 24.02% -51.06% -219.28%
Invested Capital Q/Q Growth		 -5.34% -3.27% 45.90% 13.64% -1.95% -3.82% -6.00% 4.07% -4.14% 2.96% 3.73%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 46.69% 44.65% 43.84% 40.59% 46.29% 39.72% 41.51% 42.56% 41.90% 45.39% 45.47%
EBITDA Margin		 13.11% 10.35% 7.41% 6.10% 8.10% 8.08% -3.36% 3.91% 2.18% 9.90% 7.96%
Operating Margin		 7.98% 3.98% 1.65% 0.99% 1.61% 5.68% -10.82% -3.30% -4.55% 3.89% 2.82%
EBIT Margin		 9.34% 6.16% 3.11% 1.62% 2.60% 5.56% -9.90% -1.65% -4.31% 4.45% 3.12%
Profit (Net Income) Margin		 7.36% 5.22% 2.22% 0.68% 1.64% 4.11% -8.74% -1.79% -3.58% 3.79% 2.33%
Tax Burden Percent		 83.62% 92.91% 84.12% 77.70% 86.99% 83.46% 83.51% 86.28% 76.45% 90.27% 80.76%
Interest Burden Percent		 94.19% 91.10% 84.90% 53.92% 72.21% 88.51% 105.76% 125.65% 108.39% 94.25% 92.43%
Effective Tax Rate		 16.38% 7.09% 15.88% 22.30% 13.01% 16.54% 0.00% 0.00% 0.00% 9.73% 19.24%
Return on Invested Capital (ROIC)		 12.46% 6.62% 1.99% 1.03% 1.93% 7.27% -9.91% -2.65% -3.64% 3.91% 2.73%
ROIC Less NNEP Spread (ROIC-NNEP)		 10.02% 3.03% 48.77% 1.74% 1.12% 9.07% 5.80% 0.31% -9.80% 21.53% 0.78%
Return on Net Nonoperating Assets (RNNOA)		 -1.14% -0.44% 0.31% -0.08% -0.10% -1.19% -0.12% 0.02% -0.16% 0.11% -0.01%
Return on Equity (ROE)		 11.32% 6.18% 2.30% 0.95% 1.83% 6.08% -10.03% -2.63% -3.80% 4.02% 2.72%
Cash Return on Invested Capital (CROIC)		 15.45% 19.61% -22.20% -37.01% -42.09% -40.63% -0.81% 7.15% 8.22% 0.95% -6.23%
Operating Return on Assets (OROA)		 9.87% 6.21% 2.76% 1.35% 2.16% 5.06% -8.21% -1.29% -3.31% 3.34% 2.53%
Return on Assets (ROA)		 7.77% 5.25% 1.97% 0.57% 1.36% 3.74% -7.25% -1.40% -2.74% 2.84% 1.89%
Return on Common Equity (ROCE)		 11.32% 6.18% 2.30% 0.95% 1.83% 6.08% -10.03% -2.63% -3.80% 4.02% 2.72%
Return on Equity Simple (ROE_SIMPLE)		 11.85% 0.00% 7.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 2.06 1.03 0.41 0.26 0.42 1.74 -2.02 -0.65 -0.84 1.15 0.77
NOPAT Margin		 6.67% 3.70% 1.39% 0.77% 1.40% 4.74% -7.57% -2.31% -3.18% 3.51% 2.27%
Net Nonoperating Expense Percent (NNEP)		 2.44% 3.59% -46.78% -0.71% 0.81% -1.80% -15.72% -2.96% 6.16% -17.62% 1.94%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.92% 0.33% 0.20% 0.34% 1.40% -1.68% -0.54% -0.70% 0.97% 0.64%
Cost of Revenue to Revenue		 53.31% 55.35% 56.16% 59.41% 53.71% 60.28% 58.49% 57.44% 58.10% 54.61% 54.53%
SG&A Expenses to Revenue		 32.89% 33.75% 33.55% 30.44% 34.35% 28.12% 38.90% 34.09% 33.90% 30.97% 30.53%
R&D to Revenue		 5.82% 6.92% 6.65% 6.53% 7.21% 5.92% 9.19% 7.98% 8.90% 7.35% 7.64%
Operating Expenses to Revenue		 38.72% 40.67% 42.19% 39.60% 44.68% 34.04% 52.32% 45.86% 46.44% 41.51% 42.65%
Earnings before Interest and Taxes (EBIT)		 2.89 1.72 0.93 0.55 0.79 2.04 -2.64 -0.46 -1.13 1.46 1.06
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 4.06 2.89 2.21 2.07 2.45 2.96 -0.90 1.10 0.57 3.25 2.70
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.96 1.72 1.62 1.24 0.91 1.07 0.87 0.89 0.96 0.90 1.63
Price to Tangible Book Value (P/TBV)		 3.33 2.85 4.33 3.28 2.28 2.49 2.06 2.09 2.22 2.01 3.52
Price to Revenue (P/Rev)		 1.44 1.34 1.33 1.01 0.75 0.81 0.68 0.75 0.83 0.82 1.41
Price to Earnings (P/E)		 16.57 17.70 22.43 26.69 32.15 36.77 0.00 0.00 0.00 0.00 288.60
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 6.04% 5.65% 4.46% 3.75% 3.11% 2.72% 0.00% 0.00% 0.00% 0.00% 0.35%
Enterprise Value to Invested Capital (EV/IC)		 2.32 2.04 1.64 1.22 0.92 1.06 0.87 0.89 0.95 0.90 1.63
Enterprise Value to Revenue (EV/Rev)		 1.25 1.10 1.31 1.09 0.81 0.85 0.67 0.74 0.79 0.79 1.41
Enterprise Value to EBITDA (EV/EBITDA)		 8.55 8.27 11.46 11.95 10.31 11.40 12.88 16.05 24.93 22.38 22.35
Enterprise Value to EBIT (EV/EBIT)		 11.33 11.57 17.51 22.05 24.89 25.70 115.31 0.00 0.00 0.00 184.68
Enterprise Value to NOPAT (EV/NOPAT)		 14.31 15.37 25.18 35.39 46.31 38.91 5,773.14 0.00 0.00 0.00 1,424.88
Enterprise Value to Operating Cash Flow (EV/OCF)		 11.55 8.37 10.06 17.10 16.76 28.92 11.66 7.71 8.52 12.31 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 15.06 10.06 0.00 0.00 0.00 0.00 0.00 11.90 11.01 92.80 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.18 0.16 0.25 0.31 0.26 0.24 0.21 0.18 0.16 0.14 0.15
Long-Term Debt to Equity		 0.13 0.12 0.16 0.19 0.17 0.17 0.14 0.12 0.10 0.09 0.08
Financial Leverage		 -0.11 -0.15 0.01 -0.05 -0.09 -0.13 -0.02 0.05 0.02 0.01 -0.01
Leverage Ratio		 1.57 1.52 1.63 1.53 1.51 1.46 1.55 1.54 1.52 1.49 1.47
Compound Leverage Factor		 1.48 1.38 1.38 0.83 1.09 1.30 1.64 1.93 1.64 1.41 1.35
Debt to Total Capital		 14.99% 13.90% 20.16% 23.85% 20.41% 19.42% 17.05% 15.21% 14.14% 12.55% 12.85%
Short-Term Debt to Total Capital		 3.71% 3.67% 7.74% 9.18% 6.56% 6.05% 5.74% 5.31% 5.51% 5.12% 6.19%
Long-Term Debt to Total Capital		 11.28% 10.23% 12.42% 14.67% 13.85% 13.37% 11.31% 9.90% 8.63% 7.43% 6.66%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 85.01% 86.10% 79.84% 76.15% 79.59% 80.58% 82.95% 84.79% 85.86% 87.45% 87.15%
Debt to EBITDA		 0.89 0.95 1.81 2.78 2.68 2.48 3.10 3.28 4.49 3.70 2.02
Net Debt to EBITDA		 -1.35 -1.81 -0.16 0.96 0.81 0.44 -0.25 -0.15 -1.16 -0.79 -0.04
Long-Term Debt to EBITDA		 0.67 0.70 1.11 1.71 1.82 1.71 2.06 2.13 2.74 2.19 1.05
Debt to NOPAT		 1.49 1.76 3.97 8.22 12.02 8.47 1,389.39 -21.17 -8.20 -5.70 128.85
Net Debt to NOPAT		 -2.26 -3.37 -0.36 2.85 3.63 1.49 -110.48 0.97 2.12 1.22 -2.39
Long-Term Debt to NOPAT		 1.12 1.30 2.45 5.06 8.16 5.83 921.63 -13.78 -5.01 -3.38 66.78
Altman Z-Score		 4.63 4.52 3.11 2.70 2.46 2.90 2.63 2.71 2.76 2.69 3.79
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.25 3.53 2.15 2.24 2.26 2.47 2.39 2.42 2.31 2.20 2.22
Quick Ratio		 2.35 2.61 1.27 1.39 1.29 1.54 1.38 1.38 1.14 1.12 1.20
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1.51 5.70 -25 -37 -39 -36 -2.82 7.79 9.66 4.73 -5.64
Operating Cash Flow to CapEx		 2,255.11% 1,520.13% 610.29% -1,610.76% 841.39% 1,587.12% 2,417.03% -148.92% 857.49% -191.39% -514.75%
Free Cash Flow to Firm to Interest Expense		 8.98 37.22 -176.03 -147.64 -177.69 -152.63 -18.56 65.49 101.74 56.31 -70.52
Operating Cash Flow to Interest Expense		 36.78 30.60 14.82 -20.12 19.40 11.06 36.41 -5.78 36.74 -12.17 -41.44
Operating Cash Flow Less CapEx to Interest Expense		 35.15 28.59 12.39 -21.37 17.10 10.36 34.91 -9.66 32.45 -18.52 -49.49
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.06 1.01 0.89 0.84 0.83 0.91 0.83 0.78 0.77 0.75 0.81
Accounts Receivable Turnover		 6.11 6.26 5.53 4.75 4.97 5.48 5.79 4.55 4.78 4.11 4.72
Inventory Turnover		 3.16 3.11 2.37 2.67 2.55 3.21 2.51 2.49 2.31 2.22 2.34
Fixed Asset Turnover		 41.15 39.01 30.39 31.66 31.62 34.18 27.72 26.43 25.31 24.65 25.78
Accounts Payable Turnover		 8.83 10.27 6.90 9.83 8.32 11.14 5.14 5.58 5.21 3.36 3.74
Days Sales Outstanding (DSO)		 59.74 58.30 66.02 76.86 73.42 66.57 63.03 80.14 76.43 88.80 77.37
Days Inventory Outstanding (DIO)		 115.54 117.37 153.87 136.82 143.09 113.78 145.16 146.32 157.70 164.26 156.28
Days Payable Outstanding (DPO)		 41.35 35.54 52.92 37.14 43.89 32.76 71.06 65.42 70.06 108.77 97.52
Cash Conversion Cycle (CCC)		 133.93 140.13 166.98 176.54 172.62 147.59 137.13 161.04 164.07 144.29 136.13
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 69 66 97 110 108 104 98 102 98 100 104
Invested Capital Turnover		 1.87 1.79 1.44 1.34 1.38 1.53 1.31 1.15 1.14 1.11 1.20
Increase / (Decrease) in Invested Capital		 0.56 -4.67 25 38 39 37 0.80 -8.44 -11 -3.58 6.41
Enterprise Value (EV)		 159 136 159 134 99 111 85 90 93 90 170
Market Capitalization		 184 165 161 123 91 106 86 91 97 93 171
Book Value per Share		 $7.73 $7.92 $8.16 $7.97 $8.02 $8.06 $8.03 $8.21 $8.16 $8.30 $8.36
Tangible Book Value per Share		 $4.56 $4.77 $3.06 $3.01 $3.20 $3.45 $3.40 $3.48 $3.52 $3.72 $3.88
Total Capital		 110 112 124 131 126 124 120 121 119 118 120
Total Debt		 17 16 25 31 26 24 20 18 17 15 15
Total Long-Term Debt		 12 11 15 19 17 17 14 12 10 8.81 7.98
Net Debt		 -25 -30 -2.25 11 7.77 4.22 -1.62 -0.84 -4.33 -3.19 -0.29
Capital Expenditures (CapEx)		 0.27 0.31 0.34 0.32 0.51 0.16 0.23 0.46 0.41 0.53 0.64
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 22 20 28 37 36 35 28 31 28 31 36
Debt-free Net Working Capital (DFNWC)		 64 66 55 57 54 54 50 50 49 49 51
Net Working Capital (NWC)		 60 61 46 45 45 47 44 44 43 43 44
Net Nonoperating Expense (NNE)		 -0.21 -0.42 -0.25 0.03 -0.07 0.23 0.31 -0.15 0.10 -0.09 -0.02
Net Nonoperating Obligations (NNO)		 -25 -30 -2.35 11 7.67 4.12 -1.62 -0.84 -4.33 -3.19 -0.29
Total Depreciation and Amortization (D&A)		 1.17 1.17 1.28 1.52 1.66 0.92 1.74 1.57 1.70 1.79 1.64
Debt-free, Cash-free Net Working Capital to Revenue		 17.51% 16.48% 23.13% 29.96% 29.15% 26.42% 22.29% 25.54% 23.88% 27.14% 29.34%
Debt-free Net Working Capital to Revenue		 50.12% 53.19% 45.68% 46.57% 43.89% 41.59% 39.58% 41.36% 41.81% 43.00% 42.30%
Net Working Capital to Revenue		 46.91% 49.86% 37.73% 36.80% 37.11% 35.86% 34.19% 36.08% 36.26% 37.67% 36.17%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.12 $0.06 $0.02 $0.04 $0.12 ($0.19) ($0.04) ($0.08) $0.10 $0.06
Adjusted Weighted Average Basic Shares Outstanding		 0.00 11.46M 12.03M 12.23M 12.19M 12.15M 12.18M 12.22M 12.21M 12.20M 12.25M
Adjusted Diluted Earnings per Share		 $0.00 $0.11 $0.05 $0.02 $0.04 $0.13 ($0.19) ($0.04) ($0.08) $0.10 $0.06
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 11.78M 12.16M 12.33M 12.25M 12.24M 12.18M 12.22M 12.21M 12.20M 12.42M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 12.16M 12.49M 12.52M 12.37M 12.37M 12.49M 12.48M 12.48M 12.50M 12.56M
Normalized Net Operating Profit after Tax (NOPAT)		 2.06 1.03 0.41 0.26 0.42 1.74 -1.80 -0.50 -0.75 1.34 1.37
Normalized NOPAT Margin		 6.67% 3.70% 1.39% 0.77% 1.40% 4.74% -6.75% -1.77% -2.87% 4.07% 4.05%
Pre Tax Income Margin		 8.80% 5.62% 2.64% 0.87% 1.88% 4.92% -10.47% -2.07% -4.68% 4.20% 2.88%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 17.21 11.24 6.62 2.17 3.60 8.70 -17.35 -3.90 -11.92 17.39 13.21
NOPAT to Interest Expense		 12.28 6.73 2.96 1.03 1.93 7.42 -13.27 -5.45 -8.79 13.71 9.63
EBIT Less CapEx to Interest Expense		 15.58 9.22 4.19 0.92 1.29 8.00 -18.86 -7.78 -16.20 11.04 5.16
NOPAT Less CapEx to Interest Expense		 10.65 4.72 0.53 -0.22 -0.37 6.72 -14.77 -9.34 -13.07 7.36 1.58
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 36.66% 36.04% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

inTEST Financials - Frequently Asked Questions

According to the most recent income statement we have on file, inTEST's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

inTEST's net income appears to be on an upward trend, with a most recent value of -$2.53 million in 2025, falling from $1.86 million in 2015. The previous period was $2.89 million in 2024. See inTEST's forecast for analyst expectations on what's next for the company.

inTEST's total operating income in 2025 was -$3.73 million, based on the following breakdown:
  • Total Gross Profit: $48.92 million
  • Total Operating Expenses: $52.65 million

Over the last 10 years, inTEST's total revenue changed from $38.89 million in 2015 to $113.83 million in 2025, a change of 192.7%.

inTEST's total liabilities were at $47.69 million at the end of 2025, a 9.2% decrease from 2024, and a 1,074.9% increase since 2015.

In the past 10 years, inTEST's cash and equivalents has ranged from $7.61 million in 2019 to $45.26 million in 2023, and is currently $14.22 million as of their latest financial filing in 2025.

Over the last 10 years, inTEST's book value per share changed from 3.40 in 2015 to 8.30 in 2025, a change of 144.1%.


Related Companies

Financial statements for NYSE:INTT last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Forget SpaceX, this is Elon’s Next Breakthrough
Jeff Brown and Marc Chaikin - two investors who called Nvidia a decade ago - say Elon Musk's newly filed AI pa...
Brownstone Research | Sponsoredtc pixel